Antituberculosis Treatment in a Patient with Celiac Disease

Arch Bronconeumol (Engl Ed). 2018 Jun;54(6):337-338. doi: 10.1016/j.arbres.2017.12.009. Epub 2018 Feb 14.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Celiac Disease / complications*
  • Celiac Disease / diet therapy
  • Diarrhea / chemically induced
  • Diarrhea / etiology
  • Diet, Gluten-Free
  • Drug Compounding
  • Drug Substitution
  • Drug Therapy, Combination
  • Ethambutol / therapeutic use
  • Glutens
  • Hemoptysis / etiology
  • Humans
  • Isoniazid / adverse effects*
  • Isoniazid / therapeutic use
  • Male
  • Metronidazole / therapeutic use
  • Moxifloxacin / therapeutic use
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Smoking / adverse effects
  • Tomography, X-Ray Computed
  • Tuberculosis, Pulmonary / complications
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents
  • Metronidazole
  • Pyrazinamide
  • Glutens
  • Ethambutol
  • Moxifloxacin
  • Isoniazid
  • Rifampin